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Since our commentary on the likelihood of pigs transmitting severe 
acute	respiratory	syndrome	coronavirus	2	(SARS-CoV-2)	to	humans	
published in March 2020,1	 the	World	Health	Organization	 (WHO)	
has	upgraded	SARS-CoV-2	 infection	to	a	global	pandemic	 (https://
www.who.int/dg/speec	hes/detai	l/who-direc	tor-gener	al-s-openi	
ng-remar	ks-at-the-media	-brief	ing-on-covid	-19---11-march	-2020)	
and the virus has spread to all continents with direct impact in 
most	countries.	Updated	SARS-CoV-2	data	in	humans	are	provided	
in	Table	1.	This	 synopsis	 summarizes	 the	 latest	 findings	on	animal	
sources	that	could	pose	a	risk	for	human	SARS-CoV-2	infection	and	
hence may be important during xenotransplantation.
The	 novel	 SARS-CoV-2	 was	 initially	 observed	 with	 severe	
lung	 disease	 designated	 as	 coronavirus	 disease	 2019	 (COVID-19)	
in	 a	 cluster	of	 patients	 in	Wuhan,	Hubei	Province	 in	China	during	
December 2019.2	 Coronavirus	 species	 typically	 cause	 respiratory	
and gastrointestinal sickness in both humans and animals.3 It is rec-
ognized	that	SARS-CoV-2	can	be	transmitted	through	aerosols	and	
direct or indirect contact.4-6	However,	the	role	of	animals	in	human	
infections is less clear. One of the earliest published studies investi-
gating	the	ability	of	SARS-CoV-2	to	replicate	in	various	animal	spe-
cies found that the virus does not infect farm animals including pigs, 
chickens, and ducks.7 In support of these early results, an ongoing 
study	conducted	at	the	Friedrich	Loeffler	Institute	in	Germany	fur-
ther confirmed that pigs and chickens are not susceptible to intra-
nasal	 infection	 with	 SARS-CoV-2	 (https://prome	dmail.org/prome	
d-post/?id=7196506).	Results	from	experimental	infection	trials	are	
summarized	 in	Table	2.	 Furthermore,	 a	 large	Chinese	 study	 inves-
tigated	naturally	occurring	SARS-CoV-2	 infection	 in	various	animal	
species by examining antibody levels and included serum samples 
from	187	pigs,	107	cattle,	133	sheep,	18	horses,	153	chickens,	and	
154	ducks	which	all	tested	negative.
It appears that ferrets, cats and to some degree also dogs are 
permissive	to	SARS-CoV-2	infection.	In	ferrets,	experimental	infec-
tion resulted in virus replication in the upper respiratory tract for up 
to 8 days without clinical signs or mortality.7 These findings were 
essentially confirmed by other groups who also established that 
naïve ferrets can be infected via contact exposure (https://prome 
dmail.org/prome	d-post/?id=7196506)	 or	 airborne	 transmission.9,10 
Furthermore,	minks	with	naturally	 acquired	SARS-CoV-2	 infection	
have been identified (Table 3) confirming that the Mustelidae family, 
which includes ferrets, minks but also weasels, badgers, and otters, 
appears	susceptible	to	SARS-CoV-2	infection.
Evidence	that	pets	may	be	susceptible	to	SARS-CoV-2	arose	first	via	
an experimental infection trial.7	Specifically,	2-6	months	old	cats	were	
intranasally	inoculated	with	SARS-CoV-2	and	viral	RNA	was	detected	in	
the	respiratory	tract	6	days	post-infection.	When	the	cats	were	placed	in	
contact	with	uninfected	cats,	SARS-CoV-2	transmission	occurred	after	
3	days	and	antibodies	against	SARS-CoV-2	were	detected	in	infected	
and exposed cats (Table 2).7 Similar findings were reproduced in US cats 
recently.11	 Additional	 accumulated	 evidence	 during	 a	 seroprevalence	
study	 further	 supports	 that	 SARS-CoV-2	 is	 indeed	 capable	 of	 enter-
ing the feline population.12	A	total	of	145	cat	serum	samples	collected	
from pet hospitals and animal shelters in Wuhan before and during the 
COVID-19	outbreak	were	tested.	Approximately	13.7%	(15/102)	of	the	
samples collected during the outbreak were found positive by three as-
says	while	39	samples	collected	prior	to	the	COVID-19	outbreak	were	
all negative.12 Furthermore, several domestic cats, lions, and tigers with 
naturally	acquired	SARS-CoV-2	infection	have	been	identified	(Table	3).	
This	is	an	open	access	article	under	the	terms	of	the	Creative	Commons	Attribution	License,	which	permits	use,	distribution	and	reproduction	in	any	medium,	
provided the original work is properly cited.
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The	susceptibility	of	dogs	to	SARS-CoV-2	has	also	been	investigated.	
After	experimental	infection	they	may	become	infected	at	a	low	level	
with limited transmission.7	Natural	infection,	as	evidenced	by	the	pres-
ence	of	antibodies,	SARS-CoV-2	RNA	or	both,	has	been	identified	in	se-
lected	dogs	in	close	contact	with	COVID-19	patients	(Table	3).	A	recent	
French study, which investigated nine cats and 12 dogs in close contact 
with	a	cluster	of	COVID-19	patients,	was	unable	to	detect	evidence	of	
SARS-CoV-2	infection	in	any	of	the	animals.13	Finally,	the	Chinese	se-
rosurveillance study that investigated farm animals also tested serum 
samples	from	487	dogs	and	87	cats	collected	between	November	2019	
and March 2020.8	All	samples	were	negative	for	SARS-CoV-2	antibod-
ies,8 in accordance with the French study.13
In	 summary,	 since	 SARS-CoV-2	 emerged	 in	 the	 human	 pop-
ulation towards the end of 2019, it has been spreading at a high 
rate.	 There	 is	 strong	 evidence	 that	 SARS-CoV-2	 from	 COVID-19	
infected humans can spillover to animal species within the families 
Mustelidae, Felinae, and Caninae. Infections are frequently subclini-
cal	but	occasional	clinical	signs	can	be	observed	(Table	3).	Based	on	
available	serological	surveys,	these	are	likely	localized	rare	events;	
the	true	extent	of	human-to-animal	infections	requires	further	in-
vestigations.	 Moreover,	 animal-to-human	 SARS-CoV-2	 infection	
as	well	as	natural	animal-to-animal	transmission	has	yet	to	be	con-
firmed and none of the species considered to be susceptible to 
the virus at this point are presently used for xenotransplantation. 
Despite	not	being	affected	by	SARS-CoV-2	directly,	pigs	are	being	
used	 to	 test	 novel	 SARS-CoV-2	 vaccines	 for	 possible	 human	 use	
(https://www.pirbr	ight.ac.uk/news/2020/03/pirbr	ight-begin	s-testi	
ng-new-coron	aviru	s-vacci	nes-anima	ls-help-comba	t-covid	-19).
TA B L E  1  Facts	on	high	pathogenic	human	CoVs
Virus Time of circulation
Laboratory 
confirmed cases Deaths Case fatality rate%
Country 
distribution
SARS-CoVa  2002-2003 8096 774 9.6 26
MERS-CoVb  2012-ongoing 2494 853 35 27
SARS-CoV-2c  2019-ongoing 4	248	389 294	046 14.4 Global	pandemic
Note: Situation	report	115,	14	May	2020.
aSource:	https://www.who.int/csr/sars/count	ry/table	2004_04_21/en/.	
bSource:https://www.who.int/emerg	encie	s/mers-cov/en/	
cSource:https://www.who.int/docs/defau	lt-sourc	e/coron	aviru	se/situa	tion-repor	ts/20200	512-covid	-19-sitre	p-113.pdf?sfvrs	n=feac3	b6d_2.	
TA B L E  2  Outcomes	of	SARS-CoV-2	infection	studies	in	different	animal	species
Species
Number 
used
Infection/viral 
shedding
Respiratory 
Lesions Disease Transmission Seroconversion Reference
Pigs 5 - - - - 0/5 7
9 - - - - a 
Chickens 5 - - - - 0/5 7
17 - - - - a 
Ducks 5 - - - - 0/5 7
Dogs 5 1/5 - - - 2/4 7
Cats
6-9	mo 7 7/7 - - 1/3 3/3 7
2-3	mo 7 7/7 Yes Yes 1/3 3/3
4-5	mo 6 3/3 - - 3/3 11
Ferrets 18 10/10 Yes Yes Yes 6/6 7
9 Yes Yes Yes Yes Yes a 
Bats 9 Yes - - - a 
aSource:	https://prome	dmail.org/prome	d-post/?id=7196506.	
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